Target intelligence / Profile preview

Ubiquitin specific peptidase 7 (USP7)

Target
USP7
Molecular classification
Enzyme, Deubiquitinase, Cysteine protease
01

Overview

Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme that removes ubiquitin moieties from specific protein substrates, thereby regulating their stability and function. USP7 contains several structural domains, including a N-terminal TRAF-like domain for substrate recognition, a central catalytic domain, and multiple C-terminal ubiquitin-like domains that mediate interactions with various target proteins[1][3][5]. USP7 is essential for modulating pathways such as the p53 tumor suppressor axis, DNA damage response, and multiple epigenetic processes through histone deubiquitination[3][4][5]. Aberrant USP7 activity is linked to tumorigenesis (via p53/MDM2 regulation), immune modulation, and even behaviors associated with drug addiction[1][4][7]. Targeted inhibition of USP7 has emerged as a promising anticancer approach due to its central role in maintaining protein homeostasis and regulating cell fate decisions[1][3][7].

Other names
Ubiquitin-specific protease 7Herpes virus-associated ubiquitin-specific protease (HAUSP)
02

Mechanism of action

Inhibition of deubiquitinase activity, leading to accumulation of ubiquitinated target proteins and altered stability of substrates such as p53 and MDM2[1][3][7].

03

Biological functions

Ubiquitin-mediated protein deubiquitinationRegulation of p53 pathwayRegulation of protein homeostasisDNA damage responseEpigenetic regulation (histone deubiquitination)Regulation of immune responseApoptosisCell cycle control
04

Disease associations

CancerNeurodegenerative diseaseInfection (especially herpesvirus infection)Drug addictionInflammation
05

Safety considerations

Potential for on-target toxicity due to effects on p53 and other tumor suppressor pathways[1][3][7].Risk of affecting immune regulation, given USP7's influence on Treg cells[1].Effects on normal protein homeostasis and risk of apoptosis in non-target tissues
06

Interacting drugs

P22077 (USP7 inhibitor; research/experimental)

4 more in the full profile.

07

Biomarkers

USP7 overexpression as a predictive or prognostic biomarker in certain cancers[7].Changes in p53 or MDM2 stability as pharmacodynamic markers for USP7 inhibition[1][3].

Beyond the preview

Go deeper on Ubiquitin specific peptidase 7 (USP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 7 (USP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call